- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02821988
Antenatal Testing in Obese Woman, is it Really Necessary? (ATOWS)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
- Purpose: To determine if antenatal testing improves outcomes in obese pregnant women
- Rationale: It has been well established that obese pregnant women are at increase risk of stillbirth compared to matched non obese controls. This relative risk is increased not only with increasing gestational age in obese women but with increasing severity of obesity. The increased risk of stillbirth has led some obstetricians to begin antenatal testing in obese women; however, there is little evidence that antenatal fetal surveillance improves outcomes.
- Study/Project Population: Pregnant women before 32 weeks of gestation with an initial BMI >30kg/m2
- Research Design: Randomized Controlled Trial
- Study/Project Procedures: Patients will be randomized to one of three groups: daily kick counts only, nonstress test, amniotic fluid index, and daily kick counts, and biophysical profile and daily kick counts. These patients will be randomly assigned a group in a 1:1:1 ratio using a random number generator available online. Patients assigned to the daily kick counts only group will be called weekly to ensure they are doing daily kick counts. If they are noncompliant, they will be removed from the study and will undergo nonstress tests if they meet the initial BMI criteria as is the standard practice at our institution.
- Outcomes Measured: Stillbirth, induction of labor, mode of delivery, neonatal intensive care unit admission, AGPARs <7 at 5 minutes of life
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
less then 32 weeks gestation BMI > 30kg/m2 English speaking
Exclusion Criteria:
age < 18 age >45 medical comorbidity which requires antenatal testing other than obesity unwilling to consent Non-English speaking not pregnant Gestational age >32 weeks
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Nonstress test
Subjects will undergo weekly nonstress tests beginning at 32 weeks until delivery in addition to monitoring fetal kick counts. A nonstress test is a test in which an external fetal monitor is placed on the mother to defect the fetal heart rate for 20 to 40 minutes. A test is considered reactive if there are more than 2 accelerations in fetal heart rate defined as an increase of at least 15 beats per minute lasting at least 15 seconds in a 20 minute period. |
|
|
Experimental: Biophysical profile
Subjects will undergo weekly biophysical profile testing beginning at 32 weeks until delivery in addition to monitoring fetal kick counts.
A Biophysical profile is a test using real time ultrasonography to determine the presence of absence of certain components of fetal well being.
There components include: an episode of fetal breathing lasting at least 30 seconds, 3 or more discrete body movements, 1 or more episodes of extension of a fetal extremity with return to flexion, and determination of amniotic fluid volume to detect a maximum vertical pocket of >2cm.
The duration of this test is no more than 30 minutes.
|
|
|
No Intervention: Kick counts only
Subjects will monitor fetal kick counts only.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stillbirth
Time Frame: until delivery, up to 41 weeks
|
demise of infant prior to delivery as verified by ultrasonography
|
until delivery, up to 41 weeks
|
|
Mode of delivery
Time Frame: at delivery, up to 41 weeks
|
whether the subject undergoes a vaginal delivery, cesarean delivery, or operative delivery will be recorded
|
at delivery, up to 41 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Neonatal intensive care unit admission admission
Time Frame: at delivery, up to 41 weeks
|
at delivery, up to 41 weeks
|
|
Apgar score of less than 7 at 5 minutes
Time Frame: at delivery, up to 41 weeks
|
at delivery, up to 41 weeks
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-04574-XP
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.